FY21 appropriations

Dear Research Advocate, Physician and author Dr. Alison Escalante wrote in Forbes this week: “According to [a survey commissioned by Research!America], a strong majority of Americans agree that ‘the Covid-19 pandemic is a disruptive event and requires urgent refocusing of America’s commitment to science.’” Results from the survey were also featured in The Aspen Institute’s Science & Society publication released today. See the survey here . You can use the survey data to act on behalf of science right now! Visit www.VoteScienceStrong.com to engage with candidates on the strategic significance of R&D and the multi-faceted benefits of faster medical and public health progress. Use #...
Dear Research Advocate, Wow, what a day! I hope you were among the many who joined us yesterday for the first day of Research!America’s 2020 Virtual National Health Research Forum — Straight Talk: Securing a Science-Strong Future. Here’s some of what we learned: We must "communicate, communicate, communicate — but in one voice. Leadership at all levels need to display unwavering enthusiasm for science and communicate the importance of scientific advancement like was done for [the response to] Sputnik.” —Dr. Susan Hockfield “We have an opportunity to really communicate and explain in a better way, what scientific data really mean and what is the respective context. There is no absolute truth...
Dear Research Advocate, Anticipation is building for the Research!America 2020 Virtual #RAForum: Straight Talk: Securing a Science-Strong Future , featuring federal officials, members of Congress from both sides of the aisle, and other leaders from across the R&D and public health ecosystem to explore the intersection of public and private sector-driven science and pandemic response, recovery, and preparedness. An important late-breaking addition to the Forum program is HHS Secretary Alex M. Azar II, who will be in conversation with journalist and Research!America board member Susan Dentzer. We are also excited to let you know ADM Brett P. Giroir, MD, the Assistant Secretary for Health...
The pandemic continues to reconfigure our society and our individual lives. Our R&D ecosystem is simultaneously at the center of the COVID-19 response and placed at risk by it. What is certain during this profoundly uncertain period in our nation’s history is this: inaction breeds tragedy. Inaction on Capitol Hill : Negotiations over desperately needed emergency spending legislation and FY21 appropriations are in a holding pattern. In a troubling sign, reports today surfaced that federal agencies have been told to prepare for flat funding via a CR through December. Let’s face it: federal leaders are waiting to see who blinks first, even as desperation mounts and priorities like medical...
Dear Research Advocate, Let’s cut to the chase : There is so much at stake right now as Congressional leadership and the Administration negotiate the next COVID-19 supplemental, timing included. It’s a ‘now’ situation for Americans and those who represent them; it’s a ‘now’ situation for advocates, too. Research!America sent a letter to Congressional leadership urging them to include at least $26 billion in supplemental research funding in the legislation. Now is the time to meet the moment — don’t let disappointment or fatigue set in — your advocacy has worked in the past and it can work again! Reach out now and encourage your Members of Congress to weigh in with negotiators to achieve a...
Dear Research Advocate, Phase 3 enrollment is now underway for a number of COVID-19 vaccine clinical trials. That science has moved so quickly from first identification of the virus to Phase 3 trials, speaks to remarkable public-private sector collaboration. It also speaks to the absolute necessity of taxpayer investment in basic, discovery science over many years; a lesson we must not ignore as we plan responses to the pandemics that will surely follow. To help move the massive trial enrollment process along, NIH has launched the COVID-19 Prevention Trials Network (COVPN), merging networks already funded by NIAID for HIV and other infectious disease trials. Each of the Phase 3 clinical...
Dear Research Advocate, We lost two extraordinary Civil Rights heroes this past weekend, John Lewis and C.T. Vivian. Of these courageous, committed advocates, Dr. Louis Sullivan, former HHS Secretary, Research!America emeritus board member, and friend to research advocacy, said in a statement: “ The lives of millions are better today because of their leadership and their sacrifice .” AAAS has begun a “transition to a lifelong commitment of actions to eradicate anti-Black racism in academia and STEM.” AAAS CEO and Research!America board member Dr. Sudip Parikh is leading the three-phase effort. You can review the first phase of the draft plan now. AAAS welcomes your feedback; please email...
Dear Research Advocate, We sent a letter to President Trump yesterday in support of Dr. Anthony Fauci , noting: “the depth of expertise he brings to COVID-19 response efforts is an asset our nation simply cannot afford to forsake.” A conversation with the inimitable Dr. Fauci will be among those featured at our virtual National Health Research Forum, September 8-10, 2020. Please mark the dates and look for more information soon. Good News : To the relief of many students and universities, the Administration earlier this week rescinded a proposed policy which would have denied visas to international students forced by the pandemic to engage in remote learning at our nation’s universities and...
Dear Research Advocate, Fourth of July, typically a day to unwind and celebrate, comes to us this year at a fraught time in our fight against a deadly pandemic. Evidence-based public health practices to mitigate the virus’s spread have been too often politicized and unheeded, leading to adherence gaps by some that place many others at risk. Cautious optimism from public health experts that we were on a path to containing the virus is being overtaken by alarm. Public health officials in communities across the country are being physically threatened while laboring under poorly-resourced conditions. An important time to hear from Dr. Tom Frieden, former CDC Director and current President and...
Dear Research Advocate, Our nation’s research enterprise – and thus our society – has long benefitted mightily from the contributions of foreign-born scientists and engineers. In fact, nearly a third of the STEM workforce is foreign-born . A series of immigration-related actions by the executive branch, some already taken and others considered imminent, imperil academic, industry, and independent research across the country with consequences for our economy, our health, and our well-being. We are hosting an alliance member meeting on the state of play and advocacy opportunities next Monday, June 22 at 2 p.m. ET. Alliance members can register here . On Capitol Hill : Recent reports are that...

Pages

Sidebar Quote

The capabilities are enormous, a little bit of research can pay off quite a bit in the long run.
Paul D’ Addario, retinitis pigmentosa patient